Osteopontin: Versatile modulator of liver diseases (Q38108842)

29 August 2017

title

Osteopontin: Versatile modulator of liver diseases (English)

1 reference

29 August 2017

Sumiko Nagoshi

1

1 reference

29 August 2017

publication date

20 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

44

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

22-30

1 reference

Transformed mammalian cells secrete specific proteins and phosphoproteins

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Overexpression of osteopontin in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin: regulation in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

The regulation and role of osteopontin in malignant transformation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Analysis of the alpha4beta1 integrin-osteopontin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha(4) integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Intracellular osteopontin (iOPN) and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin modulates CD44‐dependent chemotaxis of peritoneal macrophages through G‐protein‐coupled receptors: Evidence of a role for an intracellular form of osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Effects and regulation of osteopontin in rat hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

The role of Hedgehog signaling in fibrogenic liver repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Increased production of sonic hedgehog by ballooned hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Natural killer and natural killer T cells in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Specific expression of osteopontin and S100A6 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin: an effector and an effect of tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Cyclooxygenase‐2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide -443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12166

21 January 2018

Identifiers

DOI

10.1111/HEPR.12166

1 reference

29 August 2017

1 reference